Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Eli Lilly Sweden Aktiebolag
AB
Active
Org 5561351171
Gustav Iii:S Boulevard 42, 169 73
Solna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1970
59 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Eli Lilly Sweden Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
199M
397M
596M
795M
501M
2020
503M
2021
455M
2022
648M
2023
691M
2024
EBITDA
SEK millions
0M
11M
22M
33M
44M
23M
2020
20M
2021
23M
2022
38M
2023
26M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
501 384
502 783
454 810
647 576
691 195
Staff expenses
—
—
—
—
—
EBITDA
23 094
20 362
22 953
37 708
25 910
Depreciation & amort.
−336
−164
−172
−172
−188
EBIT
22 758
20 198
22 781
37 536
25 722
Net financials
−123
−20
100
2 493
1 721
Profit before tax
22 635
20 178
22 880
40 029
27 443
Tax
−5 582
−4 020
−5 148
−8 953
−6 580
Net profit
17 053
16 158
17 732
31 076
20 863
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
193 776
142 414
168 632
196 612
225 357
Equity
91 855
63 012
80 744
81 820
102 684
Long-term debt
0
0
0
0
0
Short-term debt
101 921
79 402
87 888
114 792
122 673
Total debt
101 921
79 402
87 888
114 792
122 673
Financial ratios
5-year trend
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
2020
2024
Equity ratio
45.6%
This company
38.2%
Market median
+19% vs market
2020
2024
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
2020
2024
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
2020
2024
Asset turnover
3.07×
This company
1.12×
Market median
+174% vs market
2020
2024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Eli Lilly Sweden Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
